Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
63,010,560
-
Share change
-
-3,819,204
-
Total reported value
-
$650,239,667
-
Put/Call ratio
-
65%
-
Price per share
-
$10.32
-
Number of holders
-
116
-
Value change
-
-$41,772,947
-
Number of buys
-
46
-
Number of sells
-
59
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2015
As of 31 Dec 2015,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,010,560 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, D. E. Shaw & Co., Inc., STATE STREET CORP, RTW INVESTMENTS, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.